C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2001
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087931A2 Bacterial insecticidal proteins
11/22/2001	WO2001087884A2 Polyketide derivatives
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087327A1 Method for cell adhesion and wound healing
11/22/2001	WO2001087302A1 Detection of antibodies to squalene in serum
11/22/2001	WO2001064848A9 Method and apparatus for culturing cell or tissue
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001037804A3 Preservation and formulation of bioactive materials
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells
11/22/2001	WO2001036462A3 Protein c derivatives
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001031036A3 Modified viral surface proteins which bind to cells of tumor vasculature
11/22/2001	WO2001031035A3 Heterologous production of polyketides
11/22/2001	WO2001030986A3 Human pif1 dna helicase and uses thereof
11/22/2001	WO2001029223A3 Type i membrane protein ztsl1
11/22/2001	WO2001029183A3 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase
11/22/2001	WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/22/2001	US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001	US20010044139 Method for producing L-phenylalanine
11/22/2001	US20010044133 Phage-dependent super-production of biologically active protein and peptides
11/22/2001	US20010044114 Chemically assembled nano-scale circuit elements
11/22/2001	US20010044100 Messenger RNA is used as a target (marker) which exists mainly on float in the cytoplasm and is a transcriptional product of a gene instead of using the translation product.
11/22/2001	US20010043933 Exposing bacteria culture to stress, separating the medium and stress response product from the bacteria, and filtering the separated product to form a filtrate, administering the filtrate to an animal; vaccine adjuvants, treat endotoxemia
11/22/2001	US20010043927 Method for producing a nematocidal composition by heat treating a pH-adjusted fermentation broth
11/22/2001	US20010043925 Yeast having an intracellular selenium concentration of between 1000-5000ppm and a chemotherapeutic agent; nontoxic; antineoplastic agents; dietetics
11/22/2001	US20010043886 Controls transfer of various kinds of solutions, selectively and quantitatively; for nucleic acid purification
11/22/2001	DE10032630A1 Vector encoding an expansin, useful in treatment of cellulosic materials for paper recycling, providing large-scale production
11/22/2001	DE10023893A1 New elongase gene extends 16, 18 and 20 carbon fatty acids, useful to manipulate plants to produce polyunsaturated fatty acids for the foodstuffs, cosmetics and pharmaceutical industries
11/22/2001	DE10022304A1 Kit for detecting microorganisms, e.g. in clinical or environmental samples, by hybridization, with all or most steps performed in a single vessel, comprises nucleic acid probes
11/22/2001	DE10009119A1 Vertebraten Globin Vertebrate globin
11/22/2001	CA2410181A1 Novel motor proteins and methods for their use
11/22/2001	CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	CA2409506A1 Method for cell adhesion and wound healing
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409361A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	CA2409148A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2408134A1 G-protein coupled receptors
11/22/2001	CA2407707A1 In vitro fucosylation recombinant glycopeptides
11/22/2001	CA2407259A1 Polyketide derivatives
11/21/2001	EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001	EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes
11/21/2001	EP1156116A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defense
11/21/2001	EP1156113A1 Corynebacterium glutamicum expressing heterologous amylase
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156106A1 Novel enzyme having decoloring activity and method for decoloring dyes by using the same
11/21/2001	EP1156104A1 A-agarase and process for producing the same
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155139A1 Method for microbially producing l-valine
11/21/2001	EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity
11/21/2001	EP1155134A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
11/21/2001	EP1155132A1 Production of heterologous polypeptides from freshwater caulobacter
11/21/2001	EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes
11/21/2001	EP1155130A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems
11/21/2001	EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
11/21/2001	EP1155028A1 Pigment protein from coral tissue
11/21/2001	EP1154979A1 Microbial process for preparing pravastatin
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154791A2 Neisserial vaccine compositions and methods
11/21/2001	EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0722317B1 Liposomes containing particulate materials
11/21/2001	EP0536186B1 Bone and cartilage inductive proteins
11/21/2001	CN1323356A Method for separating and characterising functions potentially present in a biological sample containing nucleic acids
11/21/2001	CN1323354A Characterisation of gene function using double stranded RNA inhibition
11/21/2001	CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof
11/21/2001	CN1323347A Means and methods for modulating stomata characteristica in plants
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323343A Photobioreactor
11/21/2001	CN1322815A Prepn and application of antibacterial peptide Pichia yeast
11/21/2001	CN1322814A Prepn and application of antibacterial peptide beer yeast
11/21/2001	CN1322768A Polyhydroxy alkanoate and process for producing them with microbe
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1075112C Producing process of HEV Protein and method of testing HEV infection
11/21/2001	CN1075078C Producing process of stem cell factor
11/20/2001	US6320103 Transgenic plants with intensified osmotolerance
11/20/2001	US6320036 GbpA
11/20/2001	US6320027 Polypeptide for use in the detection of preferential viral diseases

1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 1489